SCGB1D2 inhibits growth of Borrelia burgdorferi and affects susceptibility to Lyme disease.

Autor: Strausz S; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Oral and Maxillofacial Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Department of Plastic Surgery, Cleft Palate and Craniofacial Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Abner E; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Blacker G; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Galloway S; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Hansen P; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Feng Q; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Lee BT; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Jones SE; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Haapaniemi H; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Raak S; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Nahass GR; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Richard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, USA., Sanders E; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Soodla P; Department of Infectious Diseases, Internal Medicine Clinic, Tartu University Hospital, Tartu, Estonia., Võsa U; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Esko T; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Sinnott-Armstrong N; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.; Herbold Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Weissman IL; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA., Daly M; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland., Aivelo T; Organismal and Evolutionary Biology Research Program, University of Helsinki, Helsinki, Finland., Tal MC; Institute for Stem Cell Biology & Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA. mtal@mit.edu.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. mtal@mit.edu., Ollila HM; Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland. hanna.m.ollila@helsinki.fi.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, MA, USA. hanna.m.ollila@helsinki.fi.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA. hanna.m.ollila@helsinki.fi.; Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. hanna.m.ollila@helsinki.fi.

Publikováno v: Nature communications [Nat Commun] 2024 Mar 19; Vol. 15 (1), pp. 2041. Date of Electronic Publication: 2024 Mar 19.

Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications.

Autor: Vrijmoeth HD; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands., Ursinus J; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, Location AMC, University of Amsterdam, P.O. Box 22660, Amsterdam, 1100 DD, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Botey-Bataller J; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands.; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany., Kuijpers Y; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany., Chu X; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany., van de Schoor FR; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands., Scicluna BP; Department of Applied Biomedical Science, Faculty of Health Sciences, Mater Dei Hospital, University of Malta, MSD 2080, Msida, Malta.; Centre for Molecular Medicine and Biobanking, Biomedical Sciences, University of Malta, MSD 2080, Msida, Malta., Xu CJ; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands.; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany., Netea MG; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands.; Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, 53113, Bonn, Germany., Kullberg BJ; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands., van den Wijngaard CC; National Institute for Public Health and Environment (RIVM), Center for Infectious Disease Control, Bilthoven, 3720 BA, the Netherlands., Li Y; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands.; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research, 30625, Hannover, Germany., Hovius JW; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC, Location AMC, University of Amsterdam, P.O. Box 22660, Amsterdam, 1100 DD, the Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands., Joosten LAB; Department of Internal Medicine and Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, 6500 HB, the Netherlands. leo.joosten@radboudumc.nl.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2024 Mar 21; Vol. 24 (1), pp. 337. Date of Electronic Publication: 2024 Mar 21.

Secretoglobin 3A2 protects lung from developing cigarette smoke-induced pulmonary emphysema.

Autor: Kurotani R; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yamagata, Japan. Electronic address: kurotanir@yz.yamagata-u.ac.jp., Ono S; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yamagata, Japan., Miyano Y; Genome Informatics Unit, Institute for Promotion of Medical Science Research, Yamagata University School of Medicine, Yamagata, Japan., Nakayama S; Department of Surgery, Tohoku University Graduate School of Medicine, Miyagi, Japan; Cancer Innovation Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, USA., Liu H; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA; Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, USA., Aibara D; Cancer Innovation Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, USA; Faculty of Pharmaceutical Science, Fukuoka University, Japan., Sakahara S; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yamagata, Japan., Sato M; Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, Yamagata, Japan., Sato K; Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, Yamagata, Japan., Inoue S; Department of Cardiology, Pulmonology and Nephrology, Yamagata University School of Medicine, Yamagata, Japan., Shibata Y; Department of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan., Lee MP; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA., Abe H; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yamagata, Japan., Kimura S; Cancer Innovation Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, USA.

Publikováno v: The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2023 Apr; Vol. 157, pp. 106390. Date of Electronic Publication: 2023 Feb 15.

Uterus globulin associated protein 1 (UGRP1) is a potential marker of progression of Graves' disease into hypothyroidism.

Autor: Zhou Z; The Core Laboratory in Medical Center of Clinical Research, Department of Endocrinology, Shanghai Ninth People's Hospital, State Key Laboratory of Medical Genomics, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: zhouzheng0628@126.com., Zuo CL; Department of Endocrinology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China. Electronic address: zuochl@sina.com., Li XS; Department of Endocrinology, Minhang Hospital, Fudan University, Shanghai, China. Electronic address: lixuesong_2006@126.com., Ye XP; The Core Laboratory in Medical Center of Clinical Research, Department of Endocrinology, Shanghai Ninth People's Hospital, State Key Laboratory of Medical Genomics, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: yyfp007@126.com., Zhang QY; The Core Laboratory in Medical Center of Clinical Research, Department of Endocrinology, Shanghai Ninth People's Hospital, State Key Laboratory of Medical Genomics, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: qianyuezqy@163.com., Wang P; Department of Pathology, Basic Medical College, Zhejiang Chinese Medical University, Zhejiang, China. Electronic address: wangping897@163.com., Zhang RX; Department of Thoracic Surgery, The First Hospital Affiliated to University of Science and Technology of China, Anhui, China. Electronic address: ZRX13855219010@126.com., Chen G; Department of Endocrinology, Fujian Province Hospital, Fujian, China. Electronic address: chengangfj@163.com., Yang JL; Department of Endocrinology, Minhang Hospital, Fudan University, Shanghai, China. Electronic address: jialinyang2002@163.com., Chen Y; Department of Endocrinology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China. Electronic address: 13701994461@163.com., Ma QY; Department of Endocrinology and Metabolism, Shanghai Institute of Endocrine and Metabolic Diseases, China National Research Center for Metabolic Diseases, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China. Electronic address: qinyunma@126.com., Song HD; The Core Laboratory in Medical Center of Clinical Research, Department of Endocrinology, Shanghai Ninth People's Hospital, State Key Laboratory of Medical Genomics, Shanghai Jiaotong University School of Medicine, Shanghai, China. Electronic address: huaidong_s1966@163.com.

Publikováno v: Molecular and cellular endocrinology [Mol Cell Endocrinol] 2019 Aug 20; Vol. 494, pp. 110492. Date of Electronic Publication: 2019 Jun 27.

Development of Aging-Related Emphysematous and Lymphoma-Like Lesions is Enhanced by the Lack of Secretoglobin 3A2 in Mouse Lungs.

Autor: Kurotani R; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata, 992-8510, Japan., Kurumazuka A; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata, 992-8510, Japan., Sakahara S; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata, 992-8510, Japan., Takakura K; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata, 992-8510, Japan., Yokoyama Y; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata, 992-8510, Japan., Xu L; Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Dai J; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Lee MP; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA., Kumaki N; Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, 259-1193, Japan., Abe H; Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Yamagata, 992-8510, Japan., Kimura S; Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Publikováno v: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2022 May 26; Vol. 17, pp. 1247-1260. Date of Electronic Publication: 2022 May 26 (Print Publication: 2022).